Quantifying Ocular Surface Aberrations After Tear Film Interventions

Status: Recruiting
Location: See location...
Intervention Type: Device, Drug
Study Type: Interventional
Study Phase: Phase 4
SUMMARY

The CA-800 Corneal Analyzer (Visia Imaging S.R.L., Italy) is a device that can measure small imperfections in the tear film when the eyes are open. The goal of this study is to see if the device can detect changes in the tear film after instillation of an eye drop or when contact lenses are worn.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 17
Healthy Volunteers: t
View:

• Are at least 17 years of age and have full legal capacity to volunteer.

• Have signed the information consent letter.

• Are willing and able to follow instructions and maintain the appointment schedule.

• Habitually wear spherical soft contact lenses (no multifocal lens, no toric lens wear or extended (overnight) wear).

• Have a vertex-corrected refractive astigmatism of no more than 0.75D in each eye.

• Achieve a best corrected visual acuity of 0.00 logMAR or better in each eye.

• Agree to wear the study contact lenses for at least 6 hours.

• Have clear corneas (e.g. no central scars).

• Have no active ocular disease or inflammation.

Locations
Other Locations
Canada
Centre for Ocular Research & Education
RECRUITING
Waterloo
Contact Information
Primary
Jill Woods, MSc, MCOptom
jwoods@uwaterloo.ca
519-888-4567
Backup
Lyndon Jones, PhD, DSc, FCOptom
lwjones@uwaterloo.ca
519-888-4567
Time Frame
Start Date: 2025-06-10
Estimated Completion Date: 2025-12-15
Participants
Target number of participants: 12
Treatments
Experimental: Experimental: Systane Complete / Senofilcon A/ Somofilcon A
On the first day of the study, one drop of Systane Complete will be instilled in each eye. On the second day of the study, senofilcon A will be worn in both eyes. On the third day of the study, somofilcon A will be worn in both eyes.
Experimental: Experimental: Systane Complete/ Somofilcon A/ Senofilcon A
On the first day of the study, one drop of Systane Complete will be instilled in each eye. On the second day of the study, somofilcon A will be worn in both eyes. On the third day of the study, senofilcon A will be worn in both eyes.
Related Therapeutic Areas
Sponsors
Leads: University of Waterloo

This content was sourced from clinicaltrials.gov